Compare CNTX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTX | SEVN |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 197.5M |
| IPO Year | 2021 | 2008 |
| Metric | CNTX | SEVN |
|---|---|---|
| Price | $2.88 | $8.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $6.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 1.0M | 92.5K |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | ★ 13.02% |
| EPS Growth | ★ 69.33 | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $27.75 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $8.60 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.49 | $8.30 |
| 52 Week High | $3.30 | $13.02 |
| Indicator | CNTX | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 65.86 | 40.38 |
| Support Level | $2.07 | $8.33 |
| Resistance Level | N/A | $8.95 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 69.26 | 9.18 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.